Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment.
作者信息
Symeonidis Argiris, Germing Ulrich
机构信息
Hematology Division, Department of Internal Medicine, University of Patras, Patras, Greece.
Department of Hematology and Oncology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
出版信息
Front Oncol. 2023 Mar 8;13:1166163. doi: 10.3389/fonc.2023.1166163. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment.社论：混合性或兼具骨髓增生异常和骨髓增殖特征的疾病：诊断与治疗的当前趋势
Front Oncol. 2023 Mar 8;13:1166163. doi: 10.3389/fonc.2023.1166163. eCollection 2023.
2
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.混合性或重叠性骨髓增生异常/骨髓增殖性疾病——流行病学特征与概述
Front Oncol. 2021 Nov 16;11:778741. doi: 10.3389/fonc.2021.778741. eCollection 2021.
3
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.非典型慢性髓性白血病在临床上有别于无法分类的骨髓增生异常/骨髓增殖性肿瘤。
Blood. 2014 Apr 24;123(17):2645-51. doi: 10.1182/blood-2014-02-553800. Epub 2014 Mar 13.
4
An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.外推法的实践：非典型慢性粒细胞白血病、无法分类的骨髓增生异常综合征/骨髓增殖性肿瘤及伴有环形铁粒幼细胞的骨髓增生异常综合征/骨髓增殖性肿瘤的临床管理
Curr Hematol Malig Rep. 2016 Dec;11(6):425-433. doi: 10.1007/s11899-016-0350-1.
5
Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.慢性期以及疾病进展过程中骨髓增殖性肿瘤和骨髓增生异常/骨髓增殖性肿瘤的基因组畸变。
Int J Lab Hematol. 2015 Apr;37(2):181-9. doi: 10.1111/ijlh.12257. Epub 2014 May 21.
6
Myelodysplastic/myeloproliferative neoplasms.骨髓增生异常/骨髓增殖性肿瘤。
Semin Diagn Pathol. 2011 Nov;28(4):283-97. doi: 10.1053/j.semdp.2011.07.002.
7
Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.诊断骨髓增生异常/骨髓增殖性肿瘤：排除其他疾病的实验室检测策略。
Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x.
8
mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome.作为骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征生物标志物的突变
Biomark Res. 2017 Dec 6;5:33. doi: 10.1186/s40364-017-0113-8. eCollection 2017.
9
Current and evolving understanding of atypical chronic myeloid leukemia.当前对非典型慢性髓性白血病的认识及进展。
Blood Rev. 2019 Jan;33:74-81. doi: 10.1016/j.blre.2018.07.004. Epub 2018 Jul 29.
10
Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征的临床管理
Cancer Biol Med. 2016 Sep;13(3):360-372. doi: 10.20892/j.issn.2095-3941.2016.0043.
引用本文的文献
1
How we diagnose Myelodysplastic syndromes.我们如何诊断骨髓增生异常综合征。
Front Oncol. 2024 Sep 13;14:1415101. doi: 10.3389/fonc.2024.1415101. eCollection 2024.
本文引用的文献
1
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications.世界卫生组织第五版分类和骨髓增生性肿瘤国际共识分类：分子时代的不断发展的指南，具有实际意义。
Curr Opin Hematol. 2023 Mar 1;30(2):53-63. doi: 10.1097/MOH.0000000000000748. Epub 2022 Dec 23.
2
Advances in myelodysplastic/myeloproliferative neoplasms.骨髓增生异常/骨髓增殖性肿瘤的进展
Virchows Arch. 2023 Jan;482(1):69-83. doi: 10.1007/s00428-022-03465-7. Epub 2022 Dec 5.
3
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。
Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.
4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
5
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
Zotero 插件